PERSISTENCE OF MALARIALANTIGEN FOLLOWING ANTIMALARIAL CHEMOTHERAPY IN KOLKATA, WEST BENGAL-Reference-Cited by-同舟云学术

PERSISTENCE OF MALARIALANTIGEN FOLLOWING ANTIMALARIAL CHEMOTHERAPY IN KOLKATA, WEST BENGAL

Published:2021-09-01 Issue: Volume: Page:21-25
ISSN:
Container-title:INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH
language:en
Short-container-title:ijsr

Author:

Majhi Tanmoy¹,Rahman Mehebubar²,Mallik Sudeshna³,Saha Pabitra⁴,Chakraborty Banya¹,Kamal Guha Subhasish⁵,Pramanik Netai³

Affiliation:

1. Department Of Microbiology, Calcutta School Of Tropical Medicine, Kolkata, West Bengal, India

2. Department Of Tropical Medicine, Calcutta School Of Tropical Medicine, Kolkata, West Bengal, India.

3. Department Of Tropical Medicine, Calcutta School Of Tropical Medicine, Kolkata, West Bengal, India

4. Department Of Zoology, P. R. Thakur Govt. College, Ganti, Thakurnagar, North 24 Parganas, West Bengal, India

5. Director, Calcutta School Of Tropical Medicine, Kolkata, West Bengal, India.

Abstract

Early diagnosis and complete treatment is one of the important aspects of malaria elimination programme worldwide. In many areas the diagnosis is based on detection of malarial antigen using commercially available rapid diagnostic kits. The problem remains with persistence of antigen following parasite clearance by proper treatment. The present work was undertaken to study the pattern of persistent antigen of P. vivax and P. falciparum following antimalarial treatment. Atotal of 300 microscopically positive mono-infected with P. vivax (160) and P. vivax (140) patients were recruited, treated with antimalarial drugs and followed up on day 3, 7, 14, 21 and 28 for persistent parasites and antigen. P. vivax specic pLDH antigen was disappeared from peripheral blood within 14 days post treatment period. P. falciparum specic HRP-2 antigen was persisted even after 28 days of treatment. Depending only on antigen based diagnosis, attention should be paid before treatment, particularly in areas with high malaria transmission

Publisher

World Wide Journals

Reference38 articles.

1. WHO, 2021. World Health Organization, Malaria fact sheet. https://www.who.int/news-room/fact-sheets/detail/malaria.

2. WHO, 2015. World Health Organization, Global technical strategy for malaria 2016-2030. https://www.who.int/docs/default-source/documents/global-technical-strategy-for-malaria-2016-2030.pdf?sfvrsn=c82afcc_0

3. NVBDCP, 2016. National Vector Borne Disease Control Programme, National Frameworkfor Malaria EliminationinIndia2016 – 2030. https://nvbdcp.gov.in/WriteReadData/l892s/National-framework-for-malaria-elimination-in-India-2016%E2%80%932030.pdf

4. WHO 1999. New Perspectives: Malaria Diagnosis. Report of joint WHO/USAID informal consultation 25–27 October 1999. Report No. WHO/CDS/RBM/2000.14, WHO/MAL/2000.1091 Geneva: World Health Organization; http://wholibdoc.who.int/hq/2000/WHO_CDS_RBM_2000.14.pdf

5. Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, Wellems TE, Rener J, Taylor DW, 1986. Secretion of a malarial histidine-rich protein (Pf HRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol. 103:1269–1277.